Original Research

Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials

Li C, Xiang A, Chen X, Yin K, Lu J, Yin W

OncoTargets and Therapy 2017, 10:3155-3168

Published Date: 27 June 2017